Logo image of COUR

COURSERA INC (COUR) Stock Fundamental Analysis

NYSE:COUR - US22266M1045 - Common Stock

11.12 USD
-0.02 (-0.18%)
Last: 8/26/2025, 8:22:47 PM
11.24 USD
+0.12 (+1.08%)
After Hours: 8/26/2025, 8:22:47 PM
Fundamental Rating

4

COUR gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 71 industry peers in the Diversified Consumer Services industry. COUR has a great financial health rating, but its profitability evaluates not so good. COUR is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year COUR was profitable.
In the past year COUR had a positive cash flow from operations.
In the past 5 years COUR always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: COUR reported negative operating cash flow in multiple years.
COUR Yearly Net Income VS EBIT VS OCF VS FCFCOUR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M -150M

1.2 Ratios

COUR has a Return On Assets (-5.19%) which is in line with its industry peers.
COUR has a Return On Equity (-8.12%) which is in line with its industry peers.
Industry RankSector Rank
ROA -5.19%
ROE -8.12%
ROIC N/A
ROA(3y)-13.24%
ROA(5y)-14.17%
ROE(3y)-19.16%
ROE(5y)-20.97%
ROIC(3y)N/A
ROIC(5y)N/A
COUR Yearly ROA, ROE, ROICCOUR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

COUR has a better Gross Margin (54.37%) than 67.61% of its industry peers.
In the last couple of years the Gross Margin of COUR has remained more or less at the same level.
COUR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 54.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.81%
GM growth 5Y0.79%
COUR Yearly Profit, Operating, Gross MarginsCOUR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

COUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
COUR has more shares outstanding than it did 1 year ago.
The number of shares outstanding for COUR has been increased compared to 5 years ago.
COUR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
COUR Yearly Shares OutstandingCOUR Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
COUR Yearly Total Debt VS Total AssetsCOUR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 2.99 indicates that COUR is not in any danger for bankruptcy at the moment.
COUR's Altman-Z score of 2.99 is fine compared to the rest of the industry. COUR outperforms 73.24% of its industry peers.
There is no outstanding debt for COUR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.99
ROIC/WACCN/A
WACC9%
COUR Yearly LT Debt VS Equity VS FCFCOUR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

COUR has a Current Ratio of 2.55. This indicates that COUR is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of COUR (2.55) is better than 77.46% of its industry peers.
A Quick Ratio of 2.55 indicates that COUR has no problem at all paying its short term obligations.
The Quick ratio of COUR (2.55) is better than 77.46% of its industry peers.
Industry RankSector Rank
Current Ratio 2.55
Quick Ratio 2.55
COUR Yearly Current Assets VS Current LiabilitesCOUR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 100.00% over the past year.
Looking at the last year, COUR shows a small growth in Revenue. The Revenue has grown by 7.11% in the last year.
COUR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 30.38% yearly.
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)7.11%
Revenue growth 3Y18.71%
Revenue growth 5Y30.38%
Sales Q2Q%9.84%

3.2 Future

Based on estimates for the next years, COUR will show a quite strong growth in Earnings Per Share. The EPS will grow by 18.64% on average per year.
Based on estimates for the next years, COUR will show a small growth in Revenue. The Revenue will grow by 6.79% on average per year.
EPS Next Y15.5%
EPS Next 2Y15.91%
EPS Next 3Y18.64%
EPS Next 5YN/A
Revenue Next Year7.58%
Revenue Next 2Y6.6%
Revenue Next 3Y6.79%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
COUR Yearly Revenue VS EstimatesCOUR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
COUR Yearly EPS VS EstimatesCOUR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 26.48, COUR can be considered very expensive at the moment.
COUR's Price/Earnings is on the same level as the industry average.
COUR is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.08, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 24.34, COUR is valued on the expensive side.
60.56% of the companies in the same industry are more expensive than COUR, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.67. COUR is around the same levels.
Industry RankSector Rank
PE 26.48
Fwd PE 24.34
COUR Price Earnings VS Forward Price EarningsCOUR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, COUR is valued a bit cheaper than 67.61% of the companies in the same industry.
Industry RankSector Rank
P/FCF 23.33
EV/EBITDA N/A
COUR Per share dataCOUR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as COUR's earnings are expected to grow with 18.64% in the coming years.
PEG (NY)1.71
PEG (5Y)N/A
EPS Next 2Y15.91%
EPS Next 3Y18.64%

More info and screens

0

5. Dividend

5.1 Amount

COUR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

COURSERA INC

NYSE:COUR (8/26/2025, 8:22:47 PM)

After market: 11.24 +0.12 (+1.08%)

11.12

-0.02 (-0.18%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)07-24 2025-07-24/amc
Earnings (Next)10-22 2025-10-22/amc
Inst Owners79.9%
Inst Owner Change0.28%
Ins Owners6.59%
Ins Owner Change1.13%
Market Cap1.82B
Analysts74.29
Price Target12.5 (12.41%)
Short Float %3.25%
Short Ratio1.62
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)42.93%
Min EPS beat(2)36.12%
Max EPS beat(2)49.74%
EPS beat(4)4
Avg EPS beat(4)133.56%
Min EPS beat(4)36.12%
Max EPS beat(4)356%
EPS beat(8)8
Avg EPS beat(8)1329.89%
EPS beat(12)12
Avg EPS beat(12)910.27%
EPS beat(16)14
Avg EPS beat(16)685.05%
Revenue beat(2)2
Avg Revenue beat(2)0.91%
Min Revenue beat(2)0.22%
Max Revenue beat(2)1.6%
Revenue beat(4)2
Avg Revenue beat(4)0.14%
Min Revenue beat(4)-0.77%
Max Revenue beat(4)1.6%
Revenue beat(8)5
Avg Revenue beat(8)0.31%
Revenue beat(12)9
Avg Revenue beat(12)1.29%
Revenue beat(16)11
Avg Revenue beat(16)0.69%
PT rev (1m)23.53%
PT rev (3m)25.64%
EPS NQ rev (1m)9.34%
EPS NQ rev (3m)-19.53%
EPS NY rev (1m)10%
EPS NY rev (3m)10.22%
Revenue NQ rev (1m)4.33%
Revenue NQ rev (3m)3.96%
Revenue NY rev (1m)2.44%
Revenue NY rev (3m)2.44%
Valuation
Industry RankSector Rank
PE 26.48
Fwd PE 24.34
P/S 2.52
P/FCF 23.33
P/OCF 15.68
P/B 2.9
P/tB 3.03
EV/EBITDA N/A
EPS(TTM)0.42
EY3.78%
EPS(NY)0.46
Fwd EY4.11%
FCF(TTM)0.48
FCFY4.29%
OCF(TTM)0.71
OCFY6.38%
SpS4.41
BVpS3.83
TBVpS3.67
PEG (NY)1.71
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.19%
ROE -8.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 54.37%
FCFM 10.81%
ROA(3y)-13.24%
ROA(5y)-14.17%
ROE(3y)-19.16%
ROE(5y)-20.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.81%
GM growth 5Y0.79%
F-Score5
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 141.09%
Cap/Sales 5.27%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.55
Quick Ratio 2.55
Altman-Z 2.99
F-Score5
WACC9%
ROIC/WACCN/A
Cap/Depr(3y)108%
Cap/Depr(5y)109.75%
Cap/Sales(3y)3.84%
Cap/Sales(5y)3.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)100%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y15.5%
EPS Next 2Y15.91%
EPS Next 3Y18.64%
EPS Next 5YN/A
Revenue 1Y (TTM)7.11%
Revenue growth 3Y18.71%
Revenue growth 5Y30.38%
Sales Q2Q%9.84%
Revenue Next Year7.58%
Revenue Next 2Y6.6%
Revenue Next 3Y6.79%
Revenue Next 5YN/A
EBIT growth 1Y39.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year256.3%
EBIT Next 3Y79.6%
EBIT Next 5YN/A
FCF growth 1Y527.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y5081.12%
OCF growth 3Y279.12%
OCF growth 5YN/A